Company page

Immucell Corporation

Immucell Corporation is a public company traded under the ticker ICCC in the American market. The company has a market capitalization of approximately $85.85 million. Immucell focuses on developing products for the veterinary market, particularly in the area of animal health.

profileICCC:NASDAQAI content: aiUpdated June 24, 2026/company/immucell-corporation/c-e1lu3y1c
Immucell Corporation logo
Ticker
ICCC:NASDAQ
Asset type
Stock
Market cap
$85.9M
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD